XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table sets forth a summary of stock option activity under the Stock Plans for the nine months ended September 30, 2022 (shares in thousands): 
 Shares
Price (1)
Term (2)
Outstanding, December 31, 20216,824 $5.92 5.6
Granted1,243 5.64 
Forfeited(382)5.88 
Expired(163)5.76 
Exercised(517)1.86 
Outstanding, September 30, 2022 (3)(4)7,005 6.17 5.8
Vested, September 30, 2022 (3)4,543 6.15 4.0
 
(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term until the stock options expire.
(3)As of September 30, 2022, the aggregate intrinsic value of all stock options outstanding was $0.5 million. As of September 30, 2022, the aggregate intrinsic value of vested stock options was $0.4 million.
(4)The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to 0.3 million shares as of September 30, 2022.
Schedule of Stockholders Equity
The following table presents activity affecting the total number of shares available for grant under the Stock Plans for the nine months ended September 30, 2022 (in thousands):
 
Available, December 31, 20214,324 
Newly authorized by Board of Directors3,484 
Stock options granted(1,243)
RSUs granted(821)
Expired options under Stock Plans163 
Forfeited options under Stock Plans382 
Forfeited RSUs under Stock Plans514 
     Shares issued(60)
     Shares repurchased853 
Available, September 30, 20227,596 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions For the nine months ended September 30, 2022, the fair value of each stock option grant under the Stock Plans was estimated on the date of grant using the BSM option-pricing model, with the following weighted-average assumptions: 
Expected life (in years)6.0
Volatility46%
Dividend yield0%
Risk-free interest rate2.63%
Fair value per share of Common Stock on date of grant$5.64
Schedule of Stock-based Compensation Expense Stock-based compensation expense attributable to RSUs and stock options is classified as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended September 30,
 2022202120222021
Cost of revenue$535 $376 $1,616 $1,067 
Sales and marketing787 752 2,467 2,353 
General and administrative1,121 1,265 4,570 3,684 
Total$2,443 $2,393 $8,653 $7,104